Search

Author/Creator Behrens, F.

21. Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate‐to‐severe plaque psoriasis: results from EXCEED, a randomized, double‐blind head‐to‐head monotherapy study. (14th July 2021)

Authors:
Gottlieb, A.B.; Merola, J.F.; Reich, K.; Behrens, F.; Nash, P.; Griffiths, C.E.M.; Bao, W.; Pellet, P.; Pricop, L.; McInnes, I.B.
Journal:
British journal of dermatology
Issue:
Volume 185:Number 6(2021)
Page Start:
1124
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

22. Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate‐to‐severe plaque psoriasis: results from EXCEED, a randomized, double‐blind head‐to‐head monotherapy study. (1st December 2021)

Authors:
Gottlieb, A.B.; Merola, J.F.; Reich, K.; Behrens, F.; Nash, P.; Griffiths, C.E.M.; Bao, W.; Pellet, P.; Pricop, L.; McInnes, I.B.
Journal:
British journal of dermatology
Issue:
Volume 185:Number 6(2021)
Page Start:
1124
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

23. FRI0054 CHANGES IN DEPRESSIVE SYMPTOMS IN RHEUMATOID ARTHRITIS (RA) PATIENTS DURING TOCILIZUMAB (TCZ) THERAPY: THE GERMAN NONINTERVENTIONAL ARATA STUDY. (2nd June 2020)

Authors:
Behrens, F.; Burmester, G. R.; Feuchtenberger, M.; Kellner, H.; Kühne, C.; Liebhaber, A.; Sieburg, M.; Wassenberg, S.; Luig, C.; Hofmann, M. W.; Amberger, C.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79(2020)Supplement 1
Page Start:
603
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

24. FRI0117 Tocilizumab use directly after sdmard failure shows higher response rates and a longer treatment duration. (12th June 2018)

Authors:
Behrens, F.; Biewer, W.A.; Burmester, G.-R.; Feuchtenberger, M.; Flacke, J.-P.; Hofmann, M.; Kästner, P.; Kellner, H.; Klopsch, T.; Kühne, C.; Tony, H.-P.; Amberger, C.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 77(2018)Supplement 2
Page Start:
603
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

25. FRI0199 Rituximab in Combination with Leflunomide: Results from A Multicenter Randomized Placebo Controlled Investigator Initiated Clinical Trial in Active Rheumatoid Arthritis (Amara-Study). (15th July 2016)

Authors:
Behrens, F.; Rossmanith, T.; Köhm, M.; Alten, R.; Aringer, M.; Backhaus, M.; Baerwald, C.; Burmester, G.; Feist, E.; Kellner, H.; Krüger, K.; Müller-Ladner, U.; Rubbert-Roth, A.; Tony, H.-P.; Wassenberg, S.; Burkhardt, H.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 75(2016)Supplement 2
Page Start:
502
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

27. FRI0352 PROBABILITY OF ACHIEVING LOW DISEASE ACTIVITY OR REMISSION WITH APREMILAST TREATMENT AMONG DMARD-NAIVE SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS. (2nd June 2020)

Authors:
Mease, P. J.; Kavanaugh, A.; Ogdie, A.; Wells, A. F.; Bergman, M.; Gladman, D. D.; Behrens, F.; Richter, S.; Brunori, M.; Teng, L.; Guerette, B.; Smolen, J. S.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79(2020)Supplement 1
Page Start:
771
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

28. FRI0360 IMPACT OF METHOTREXATE ON DISEASE PATTERN IN ACTIVE PSORIATIC ARTHRITIS PATIENTS ELIGIBLE FOR A RANDOMIZED CLINICAL TRIAL WITH USTEKINUMAB: COMPARATIVE BASELINE DATA FROM MULTICENTRE INVESTIGATOR-INITIATED MUST TRIAL. (2nd June 2020)

Authors:
Rossmanith, T.; Köhm, M.; Kiltz, U.; Rech, J.; Burmester, G. R.; Kellner, H.; Bulczak-Schadendorf, A.; Foldenauer, A. C.; Burkhardt, H.; Behrens, F.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79(2020)Supplement 1
Page Start:
777
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

30. LB0001 EFFICACY AND SAFETY OF UPADACITINIB VERSUS PLACEBO AND ADALIMUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO NON-BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-PsA-1): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL. (13th June 2020)

Authors:
Mcinnes, I.; Anderson, J.; Magrey, M.; Merola, J. F.; Liu, Y.; Kishimoto, M.; Jeka, S.; Pacheco Tena, C. F.; Wang, X.; Chen, L.; Zueger, P.; Pangan, A.; Behrens, F.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79(2020)Supplement 1
Page Start:
16
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗